ACO Name and Location

McLaren High Performance Network, LLC
2701 Cambridge Court
Suite 200
Auburn Hills, MI 48326

ACO Primary Contact

Kim Hamm
800-822-4950
[email protected]

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture

ADVANCED CARDIOVASCULAR CLINIC PC

N

ALBERT A. PRZYBYLSKI, D.O, PC

N

AMMAR GHANEM MD PLLC

N

ASHRAF MOSTAFA MD PLLC

N

BARBARA ANN KARMANOS CANCER HOSPITAL

N

BEECHER SURGICAL ASSOCIATES, PLLC

N

Capital Area Anesthesia PC

N

CAPITOL AREA PULMONARY ASSOCIATES PC

N

CARDIOLOGY ASSOC OF PORT HURON

N

CARDIOLOGY ASSOCIATES OF MICHIGAN, P.C.

N

CARDIOLOGY CONSULTANTS OF EAST MICHIGAN PLLC

N

CARDIOLOGY INSTITUTE OF MICHIGAN, PLLC

N

Chest And Sleep Medicine Consultants, Plc

N

COMPREHENSIVE MEDICAL GROUP PC

N

COSMETIC DERMATOLOGY AND VEIN CENTERS OF DOWNRIVER PC

N

EAGER INTERNAL MEDICINE PLLC

N

ELK RAPIDS MEDICAL CLINIC, P.C.

N

Esa M Ali MD PC

N

Foremost Podiatry Pc

N

FRED WURSTER DO PC

N

Gary E Hosey DPM PC

N

GLOBAL HOSPITALISTS PLLC

N

Heart & Vascular Institute of MI PC

N

HEART RHYTHM CLINIC OF MICHIGAN PC

N

Hesham E Gayar MD PC

N

HISHAM I AHMED MD PC

N

HURON EMERGENCY MEDICINE SPECIALISTS PLLC

N

JAPHET JOSEPH, MD PC

N

John D Arsen DPM Inc

N

JOHN KETNER

N

K MOHAN MD PC

N

Kellam & Associates, P. C.

N

LANSING SURGICAL ASSOCIATES, P.L.L.C.

N

Lapeer Pediatrics PC

N

LAPEER WOMENS HEALTH PLLC

N

Looking Glass Foot & Ankle Pc

N

LUNG HEALTH CENTER PLLC

N

Macomb Internal Medicine Pc

N

MASON MEDICAL GROUP PC

N

McLaren Caro Region

N

MCLAREN FLINT

N

MCLAREN GREATER LANSING

N

MCLAREN HOSPITAL GROUP

N

MCLAREN LAPEER REGION

N

MCLAREN MACOMB

N

McLaren Medical Group

N

McLaren Northern Michigan

N

McLaren Port Huron

N

McLaren Thumb Region

N

Michael A Kia Do Pc

N

MICHAEL J MUELLER MD PC

N

MICHIGAN INTERNAL MEDICINE ASSOCIATES, P.C.

N

MICHIGAN ORTHOPEDIC CENTER PC

N

MID MICHIGAN INTERNAL MEDICINE PC

N

MID MICHIGAN KIDNEY AND HYPERTENSION SPECIALISTS, P.C.

N

Mt Morris Medical Group Pllc

N

MUHAMMED MIRZA

N

Najjar Infectious Disease PC

N

NORTH OAKLAND NORTH MACOMB IMAGING INC

N

Northeast Surgical Group PC

N

Northern Michigan Hematology and Oncology

N

Northern Michigan Pain Specialists PC

N

Northpointe OB-GYN PC

N

OPDYKE MEDICAL PLLC

N

Orthopedic Associates of Port Huron PC

N

PARTNERS IN FAMILY MEDICINE, PLLC

N

PERRY MLK MEDICAL CENTER P.C.

N

PETOSKEY RADIATION ONCOLOGY PLC

N

PULMONARY & CRITICAL CARE ASSOCIATES PC

N

Pulmonary & Critical Care Medicine Consultants Pc

N

Pulmonary Associates PC

N

ROBERT J FRANCHI D O P C

N

ROSTAM ADULT AND PEDIATRIC MEDICINE PLLC

N

SARDELLI ORTHOPAEDICS

N

SHARMA CLINIC PLLC

N

Sunil K Kaushal, MD, P.C.

N

Surgical Consultants PLLC

N

THE DIGESTIVE DISEASE INSTITUTE PC

N

THOMAS C HOSEY DPM & ASSOCIATES PC

N

TROY GASTROENTEROLOGY PC

N

Vascular Surgery Assoc PC

N

WILFREDO RIVERA, M.D., P.C.

N

X-RAY ASSOCIATES OF PORT HURON PC

N

ACO governing body:

Member First Name Member Last Name Member Title/Position Member's Voting Power (Expressed as a percentage or number) Membership Type ACO Participant Legal Business Name and D/B/A, if applicable
David Pinelli Chairman 10 ACO Participant Representative McLaren Lapeer Region
Brad Ropp Vice Chairman 10 ACO Participant Representative McLaren Medical Group
Justin Klamerus Secretary 10 ACO Participant Representative McLaren Northern Michigan
Brian Balutanski Treasurer 10 ACO Participant Representative McLaren Macomb
Esa Ali Voting Member 10 ACO Participant Representative Esa M Ali MD PC
Lawrence Cowsill Voting Member 10 ACO Participant Representative McLaren Port Huron
Thomas Redmond Voting Member 10 Medicare Beneficiary N/A
Jessica Cromer Voting Member 10 Other N/A
Gary Wentzloff Voting Member 10 ACO Participant Representative McLaren Greater Lansing
Michael Ziccardi Voting Member 10 ACO Participant Representative McLaren Flint

Key ACO Clinical and Administrative Leadership:

ACO Executive: Gary Wentzloff

Medical Director: Michael Ziccardi, DO

Compliance Officer: Dawn Smith

Quality Assurance/Improvement Officer: Kim Hamm

Associated Committees and Committee Leadership:

Committee Name

Committee Leader Name and Position

Quality and Clinical Integration Committee

Emily Smith, D.O., Chair

Utilization Management Committee

Michael Ziccardi, D.O., Chief Medical Officer, Chair

Finance Committee

Brian Balutanski, VP/Corporate Controller

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount Shared Savings/Losses:

  • Third Agreement Period
    • Performance Year 2026, N/A
    • Performance Year 2025, N/A
  • Second Agreement Period
    • Performance Year 2024, $-3,075,634.81
    • Performance Year 2023, $0
    • Performance Year 2022, $0
    • Performance Year 2021, $5,361,143
    • Performance Year 2020, $4,779,012
  • First Agreement Period
    • Performance Year 2019, $17,316,006
    • Performance Year 2018, $6,395,854
    • Performance Year 2017, $0

Shared Savings Distribution:

  • Third Agreement Period
    • Performance Year 2026
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2025
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • Second Agreement Period
    • Performance Year 2024
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2023
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2022
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2021
      • Proportion invested in infrastructure: 33%
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 57%
    • Performance Year 2020
      • Proportion invested in infrastructure: 38% 
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 52%
  • First Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 20% 
      • Proportion invested in redesigned care processes/resources: 10%
      • Proportion of distribution to ACO participants: 70%
    • Performance Year 2018
      • Proportion invested in infrastructure: 58% 
      • Proportion invested in redesigned care processes/resources: 18%
      • Proportion of distribution to ACO participants: 24%
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A 
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2024 Quality Performance Results:

Quality performance results are based on CMS Web Interface collection type.

ACO Quality Measure Number

Measure Title

Collection Type

Rate

ACO Mean

321

CAHPS for MIPS

CAHPS for MIPS Survey

5.55

6.67

479*

Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups

Administrative Claims

0.1571

0.1517

484*

Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC)

Administrative Claims

-

37

318

Falls: Screening for Future Fall Risk

CMS Web Interface

98.12

88.99

110

Preventive Care and Screening: Influenza Immunization

CMS Web Interface

70

68.6

226

Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS Web Interface

92.16

79.98

113

Colorectal Cancer Screening

CMS Web Interface

77.46

77.81

112

Breast Cancer Screening

CMS Web Interface

76.82

80.93

438

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

CMS Web Interface

90.94

86.5

370

Depression Remission at Twelve Months

CMS Web Interface

3.03

17.35

001*

Diabetes: Hemoglobin A1c (HbA1c) Poor Control

CMS Web Interface

9.33

9.44

134

Preventative Care and Screening: Screening for Depression and Follow-Up Plan

CMS Web Interface

87.13

81.46

236

Controlling High Blood Pressure

CMS Web Interface

83.89

79.49

CAHPS-1

Getting Timely Care, Appointment, and Information

CAHPS for MIPS Survey

80.84

83.7

CAHPS-2

How Well Providers Communicate

CAHPS for MIPS Survey

91.81

93.96

CAHPS-3

Patient's Rating of Provider

CAHPS for MIPS Survey

89.7

92.43

CAHPS-4

Access to Specialists

CAHPS for MIPS Survey

78.88

75.76

CAHPS-5

Health Promotion and Education

CAHPS for MIPS Survey

69.55

65.48

CAHPS-6

Shared Decision Making

CAHPS for MIPS Survey

63.15

62.31

CAHPS-7

Health Status and Functional Status

CAHPS for MIPS Survey

74.24

74.14

CAHPS-8

Care Coordination

CAHPS for MIPS Survey

83.77

85.89

CAHPS-9

Courteous and Helpful Office Staff

CAHPS for MIPS Survey

91.37

92.89

CAHPS-11

Stewardship of Patient Resources

CAHPS for MIPS Survey

29.19

26.98

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov

*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.

*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs' providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.

Payment Rule Waivers

  • Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.

Archives of Shared Savings Program